HER Kinase Axis Receptor Dimer Partner Switching Occurs in Response to EGFR Tyrosine Kinase Inhibition despite Failure to Block Cellular Proliferation
Anjali Jain(Lewin Group (United States)), David B. Agus(California State University Los Angeles)
Cited by 67
Related Papers
Ifosfamide, Carboplatin, and Etoposide: A Highly Effective Cytoreduction and Peripheral-Blood Progenitor-Cell Mobilization Regimen for Transplant-Eligible Patients With Non-Hodgkin's Lymphoma
|Journal of Clinical Oncology|1999|303
Future cancer research priorities in the USA: a Lancet Oncology Commission
|The Lancet Oncology|2017|209
Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapies
|British Journal of Cancer|2005|69